COVID-19

AI tools and health tech can be used to help the healthcare system treat patients.

While recent data regarding remdesivir has been positive, there is still a need for medications in pill form to treat COVID-19 infections.

How community, prevention, and research-based practice could be influenced by the pandemic.

Panagis Galiatsatos, MD, MHS, joins to discuss the underlying issues and potential solutions to COVID-19 patient disparities.

Why the virus is burdening US populations similar to other diseases.

The dermatologist fields questions on possible symptoms and signs of infection that his colleagues have observed.

The Florida-based clinician shares perspective and insight into what should be prioritized or revised in specialty care.

A new study finds a multitude of factors involving organizational, interpersonal, and intrapersonal influences lead to trauma in frontline caregivers.

New data from Mount Sinai Hospital suggests anticoagulant use could improve survival rates among patients hospitalized with COVID-19.

The new recommendations call for enhanced symptom monitoring for patients experiencing gastrointestinal issues.

An expert describes how telehealth can be used during the pandemic.

A dermatologist discusses how to care for patients with psoriasis during the COVID-19 pandemic.

Enjoy our archived discussion between 4 experts on how their specialty is most affected by the pandemic.

The Chief Medical Officer of the Sickle Cell Disease Association of America discusses a recently released care provider advisory from the organization.

Telemedicine could eliminate some of the distance barriers in rural areas.

Older men might need additional care compared to women.

Evry will enable the imaging of COVID-19 patients in need of emergency care.

Jesse Wright, MD, PhD, discusses the convenience of telehealth during the COVID-19 pandemic.

In a virtual APA session, Nora D. Volkow, MD, discusses how vaping can increase the risk of individuals of developing infections from the coronavirus.

Discussing how the ACC has responded to the ongoing outbreak and the potential lasting impact of COVID-19 on the College.

Telehealth capabilities are crucial during the COVID-19 pandemic.

Higher dosages of chloroquine can lead to safety hazards.

While stay-at-home orders have slowed the spread of COVID-19, Thomas Maddox, MD, and the ACC are concerned it may be having a dangerous secondary impact.

Discussing how COVID-19 impacts the cardiovascular health of infected patients with the Chair of the ACC's Science and Quality Committee.

An expert projects annual national prevention lifeline calls will reach 3.7 million by 2023.